Progelatinase A activation during tumor cell invasion.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Invasion & Metastasis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• A polysaccharide from Hedyotis diffusa interrupts metastatic potential of lung adenocarcinoma A549 cells by inhibiting EMT via EGFR/Akt/ERK signaling pathways.

  2019cites this paper
• Proteomic profiling of isogenic primary and metastatic medulloblastoma cell lines reveals differential expression of key metastatic factors.

  2017cites this paper
• In vitro anticancer activity of the laminarans from Far Eastern brown seaweeds and their sulfated derivatives

  2017cites this paper
• F344/NTac Rats Chronically Exposed to Bromodichloroacetic Acid Develop Mammary Adenocarcinomas With Mixed Luminal/Basal Phenotype and Tgfβ Dysregulation

  2016cites this paper
• Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy

  2014cites this paper
• Endogenous and synthetic MMP inhibitors in CNS physiopathology.

  2014cites this paper
• Cell-specific and endothelium-dependent regulations of matrix metalloproteinase-2 in rat aorta

  2014cites this paper
• Encapsulated human hepatocellular carcinoma cells by alginate gel beads as an in vitro metastasis model.

  2013cites this paper
• Osteonectin (SPARC) Is a Key Regulator of Malignant Pleural Mesothelioma

  2013cites this paper
• Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing

  2012cites this paper
• Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma.

  2012cites this paper
• A novel strategy to tag MMPs-positive cells for in vivo imaging of tumor cells

  2012cites this paper
• The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system

  2011cites this paper
• Differentielle Expressionsmuster von MMP-2, MMP-9 und PCNA in verschiedenen Endometriosestadien und Endometriumkarzinomen

  2011cites this paper
• Deletion of Forkhead Box M1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells.

  2011cites this paper
• Novel Cyclopeptides for the Design of MMP Directed Delivery Devices: A Novel Smart Delivery Paradigm

  2010cites this paper
• Isolation and characterization of human monoclonal antibodies specific to MMP-1A, MMP-2 and MMP-3.

  2010cites this paper
• Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties and in vivo behavior.

  2010cites this paper
• A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells.

  2010cites this paper
• Liver Regeneration and Tumor Stimulation—A Review of Cytokine and Angiogenic Factors

  2008cites this paper
• Matrix metalloproteinase inhibitors as anticancer agents.

  2008cites this paper
• Oral and Maxillofacial Pathology: MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues

  2008cites this paper
• SPARC in cancer biology: its role in cancer progression and potential for therapy.

  2008cites this paper
• Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses.

  2007cites this paper
• Matrix Metalloproteinase Polymorphisms and Survival in Stage I Non–Small Cell Lung Cancer

  2006cites this paper
• Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy

  2006cites this paper
• Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation

  2006cites this paper
• The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis

  2006cites this paper
• Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases

  2005cites this paper
• Gabexate Mesilate Inhibits Colon Cancer Growth, Invasion, and Metastasis by Reducing Matrix Metalloproteinases and Angiogenesis

  2004cites this paper
• Type I Collagen-induced MMP-2 Activation Coincides with Up-regulation of Membrane Type 1-Matrix Metalloproteinase and TIMP-2 in Cardiac Fibroblasts*

  2003cites this paper
• Membrane type-matrix metalloproteinases (MT-MMP).

  2003cites this paper
• Effect of batimastat on Matrix metallopro- teinase-2 mRNA in rat hepatocellular carcinoma

  2003cites this paper
• Human Endometrial Epithelial Cells Modulate the Activation of Gelatinase A by Stromal Cells

  2002cites this paper
• Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion*

  2002cites this paper
• Down-Regulation of MT1-MMP Expression by the α3 Chain of Type IV Collagen Inhibits Bronchial Tumor Cell Line Invasion

  2001cites this paper
• Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.

  2001cites this paper
• Assessment of Gelatinases (MMP-2 and MMP-9 by Gelatin Zymography.

  2001cites this paper
• Increased matrix metalloproteinase expression and activation following experimental acute pancreatitis.

  2001cites this paper
• Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer.

  2000cites this paper
• Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.

  2000cites this paper
• Activation of Progelatinase B by Membranes of Human Polymorphonuclear Granulocytes

  2000cites this paper
• Interstitial Collagenase Gene Expression Correlates With In Vitro Invasion in Human Chondrosarcoma

  2000cites this paper
• Anti‐β4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP‐2 expression

  2000cites this paper
• Matrix metalloproteinases as emerging targets for cancer therapy

  2000cites this paper
• Biochemical Characterization of the Catalytic Domain of Membrane-Type 4 Matrix Metalloproteinase

  1999cites this paper
• Influence of oleic acid on the expression, activation and activity of gelatinase a produced by oncogene‐transformed human bronchial epithelial cells

  1999cites this paper
• Experimental metastasis is suppressed in MMP-9-deficient mice

  1999cites this paper
• 9,10-dimethy1-1,2-benzanthracene(DMBA)誘発ハムスター頬嚢粘膜癌の発癌過程におけるマトリックスメタロプロテアーゼ発現に関する研究

  1999cites this paper
• Expression of matrix metalloproteinases (MMP‐2 and ‐9) and tissue inhibitors of metalloproteinases (TIMP‐1 and ‐2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells

  1999cites this paper
• Cell-surface proteases in cancer

  1999cites this paper
• Measurement of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Blood and Tissues: Clinical and Experimental Applications

  1999cites this paper
• Matrix Metalloproteinases in the Hematopoietic Microenvironment.

  1999cites this paper
• Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation.

  1999cites this paper
• Granulocyte‐macrophage‐colony stimulating factor stimulates tumor invasiveness in squamous cell lung carcinoma

  1998cites this paper
• Immunological characterization of cell‐surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts

  1998cites this paper
• Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.

  1998cites this paper
• The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A

  1998cites this paper
• Phenotypic and genotypic alterations associated with the attenuation of a Theileria annulata vaccine cell line from Turkey.

  1998cites this paper
• Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2.

  1998cites this paper
• Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor

  1998cites this paper
• The Role of Proteinases in Tumor Invasion and Metastasis

  1997cites this paper
• Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells.

  1997cites this paper
• Matrix metalloproteinases in choriocarcinoma cell lines: A potential regulatory role of extracellular matrix components

  1997cites this paper
• Characterization of a Novel, Membrane-bound, 80-kDa Matrix-degrading Protease from Human Breast Cancer Cells

  1997cites this paper
• Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants

  1997cites this paper
• Activity of 72-kDa and 92-kDa matrix metalloproteinases in placental tissues of cows with and without retained fetal membranes.

  1997cites this paper
• Collagenase: a key enzyme in collagen turnover.

  1996cites this paper
• Metalloproteinase inhibitors and the prevention of connective tissue breakdown.

  1996cites this paper